Oncotelic Therapeutics (OTLC) Short Interest Ratio & Short Volume

Short interest is the volume of Oncotelic Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 2,200 shares of OTLC short. Learn More on Oncotelic Therapeutics' current short interest.

Oncotelic Therapeutics saw a decline in short interest in November. As of November 30th, there was short interest totaling 2,200 shares, a decline of 94.9% from the previous total of 43,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Oncotelic Therapeutics: Prelude Therapeutics Incorporated (13.99%), vTv Therapeutics Inc. (1.61%), Xtant Medical Holdings, Inc. (0.07%), CASI Pharmaceuticals, Inc. (1.17%), Kezar Life Sciences, Inc. (1.67%), MariMed Inc. (0.00%), Omega Therapeutics, Inc. (29.53%), Exicure, Inc. (8.54%), Atlantic Coastal Acquisition Corp. II (0.49%), Estrella Immunopharma, Inc. (0.37%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

Short selling OTLC is an investing strategy that aims to generate trading profit from Oncotelic Therapeutics as its price is falling. OTLC shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Oncotelic Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OTLC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OTLC, twice per month. The most recent reporting period available is November, 30 2024.